OL Oncology Letters 1792-1074 1792-1082 D.A. Spandidos 10.3892/ol.2016.4469 OL-0-0-4469 Articles Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report PONTIGIOVANNI 1 PELLACANIGIOVANNI 1 MARTORANADAVIDE 2 MANDELVICTOR DESMOND 1 LOSCHIPIETRO 3 POLLIOANNAMARIA 4 PECCHIANNARITA 5 DEALISCRISTINA 6 SEIDENARISTEFANIA 1 TOMASIALDO 7 Department of Surgical, Medical, Dental and Morphological Sciences with interest in Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, I-41124 Modena, Italy Department of Genetics, University of Parma, I-43125 Parma, Italy Department of Plastic Surgery, University of Modena, I-41124 Modena, Italy Department of Neurosciences, University of Padua, I-43125 Padua, Italy Department of Radiology, University of Modena and Reggio Emilia, I-41100 Modena, Italy Department of Medical Oncology, Bolzano Hospital, I-39100 Bolzano, Italy Department of Diagnostic and Clinical Medicine and Public Health, University of Modena and Reggio Emilia, I-41100 Modena, Italy Correspondence to: Dr Giovanni Ponti, Department of Surgical, Medical, Dental and Morphological Sciences with interest in Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, 71 via del Pozzo, 41124 Modena, Italy, E-mail: giovanni.ponti@unimore.it 06 2016 19 04 2016 11 6 3709 3714 12102014 23062015 Copyright © 2016, Spandidos Publications 2016

Elephantiasis neuromatosa (EN) can arise from a plexiform neurofibroma of the superficial and deep nerves developing from a hyperproliferation of the perineural connective tissue infiltrating adjacent fat and muscles. To date, the clinical association between EN and neurofibromatosis type 1 (NF1) has been poorly defined, particularly with regard to the role of lymphatic alterations and the consequent lymphedema. The present study reports the clinical and biomolecular features of EN in a NF1 patient with the clear clinical diagnostic criteria of multiple cafè-au-lait macules, neurofibromas, EN, a positive family history and a novel NF1 germline c.1541_1542del mutation. Lymphoscintigraphy (LS) highlighted marked dermal backflow in the affected limb, hypertrophy of the ipsilateral inguinal and external iliac lymph nodes, and a bilateral lower limb lymph flow delay. These data support the hypothesis that an extensive hyperproliferative process involving perineural connective, limb soft tissues, bones and the lymphatic system can be responsible for EN in NF1 patients, on the basis of adipocyte metaplasia triggered by lymphostasis and lymphedema, and bone overgrowth and gigantism caused by chronic hyperemia. LS and magnetic resonance imaging can be efficacious tools in the diagnosis and clinical characterization of the early onset of the disease.

 neurofibromatosis type 1 elephantiasis neuromatosa plexiform neurofibroma mixoglioma gelatiniforme primary lymphatic drainage Introduction

Neurofibromatosis type 1 (NF1) (MIM no. 162200), also known as von Recklinghausen disease, is clinically characterized by the presence of simple, diffuse and plexiform neurofibromas. Plexiform neurofibromas are unencapsulated, poorly-circumscribed tumors infiltrating the nerves and adjacent fat and muscles (1). The connective overgrowth can be limited to a single nerve or a plexus; in the latter case, when the plexus spreads to the epidermal and dermal tissues, it is termed molluscum fibrosum. This can occur multiple times, covering all body sites (including the forehead, temple, eyes, nape and upper lip) with the exception of the palms and soles (2). The plexiform neurofibroma variant, mixoglioma gelatiniforme, is usually soft and is located in the lower third of the leg, and when associated with lymphangiomatosis, it can give rise to elephantiasis neuromatosa (EN). EN is characterized by abnormal soft-tissue hypertrophy and bone dysplasia together with early and excessive bone growth of the affected leg compared with the contralateral leg (3,4). Pachidermocele or dermatholysis may be associated with NF1, showing an overlap of skin layers in the thorax, buttocks and roots of the limbs.

The etiology of EN is not yet fully understood, but the association of primary lymphatic dysplasia with a lymphatic proliferative process has been proposed (5–7).

The current study presents a case of NF1-associated EN with typical clinical manifestations. Written informed consent was obtained from the patient.

 Case report <sec> <title>Case history

In January 2014, the case of a female patient was brought to our attention at the Department of Dermatology of University of Modena and Reggio Emilia (Modena, Italy) due to a 29-year history of several neurofibromas and multiple (>6) cafè-au-lait macules. The patient presented with giant elephantiasis of the right leg, which had started to grow during late childhood, and had since accelerated its expansion in the following years (Fig. 1A). At birth, the patient exhibited a cafè-au-lait macule on the right thigh. By 1 year old, a semi-liquid mass had developed at the same site. The lesion was noticed by the parents and showed indolent growth with no signs of bleeding or pain. Upon histopathological examination, it presented with the aspects of a lymphangioma. Lymphedema of the ipsilateral foot and discrepant leg lengths were noted successively. In the following years, the uneven leg growth was associated with bone proliferation, which required a number of osteotomies with the aim of stopping the growth. Conventional lymphoscintigraphy (LS) was performed to assess the lower limb lymphatic drainage pathway.

The family history was suggestive of NF1, as the patient's father exhibited macrocephaly, hypertelorism, and multiple cafè-au-lait macules and neurofibromas.

Genetic testing, magnetic resonance imaging (MRI) and three-dimensional computed tomography (3D-CT) were also performed.

 MRI and 3D-CT

The MRI and 3D-CT scan study showed a preponderance of adipose tissue in the elephantiasic limb, corresponding to three-quarters of its whole volume, in addition to a severe dorso-lumbar-sacral scoliosis with convexity on the left. Two central nervous system hamartomas of the pallidus nucleous were also identified by MRI. 3D-CT revealed a mild lumbo-sacral meningocele and giant L4 neurofibroma (Fig. 1B).

 Germline mutation analysis of the NF1 gene

Genomic DNA was extracted from the peripheral blood of the patient and the patient's father using the QIAamp DNA Blood Mini kit (Qiagen Inc., Valencia, CA, USA), and stored at −20°C until use. All NF1 exons were amplified by polymerase chain reaction with intron spanning primers, as described previously (8), and then analyzed with denaturing high-performance liquid chromatography, as described previously (9). For each abnormal elution profile, genomic DNA was directly sequenced in each direction using a CEQ Dye-Terminator Cycle Sequencing kit (Beckman Coulter Inc., Miami, FL, USA) according to the manufacturer's instructions.

Mutations were checked using the Mutalyzer program (http://www.lovd.nl/mutalyzer). NF1 germline deletion g.129042_129043delAG; c.1541_1542del; p.(Gln514Argfs*43) was found in the proband and the patient's father. To the best of our knowledge, this type of mutation has not previously been described.

 Lymphedema and limb lymphatic assessment

A common tape measure was used to assess the limb circumferences of the patient. Reference circumferences were the popliteal crease, point zero (K), +30 cm (A), +20 cm (B) and +10 cm (C) in the thigh, −10 cm (D), −20 cm (E) and −30 cm (F) in the lower leg, and 10 cm proximal from the tip of the first toe (G). Leg volumes were calculated according to these measurements (10).

Lower limb lymphatic function was assessed by LS, using injections of 37-MBq 99mTc-labeled human serum albumin. Injection points were in the first, second and fourth interdigital and retromalleolar spaces of the affected and contralateral foot. Image acquisition was obtained after 60 and 240 min using a dual head γ-camera (Philips Healthcare, Andover, MA, USA) equipped with a low-energy and high-resolution collimator, and an energy peak centered on 140 KeV (window of 20%).

The criteria to define lymphatic dysfunction include delay, asymmetric or absent visualization of regional lymph nodes, and the presence of dermal backflow. Other observations include the visualization of asymmetric lymphatic channels, collateral lymphatic channels, interrupted vascular structures, and lymph nodes of the deep lymphatic system (i.e., popliteal lymph nodes following web space injection in the lower extremities) (11).

In LS, the images obtained 60 min after the injections showed bilateral lower limb lymph flow delay. Mild dermal backflow in the absence of tracer migration was observed in the affected lower limb, whilst one inguinal lymph node was observed in the left limb. Posterior images confirmed the findings, also visualizing a popliteal lymph node in the healthy (left) leg. Images acquired at 240 min showed significant dermal backflow in the right limb, and hyperplasia and hypertrophy of the inguinal and external iliac lymph nodes, in comparison to those of the left leg (Fig. 1C).

 Treatment and patient outcome

In May 2014, the patient was treated with surgery to reduce the volume of tissue in the leg region; tissue with a mass of 4.3 kg was removed. However, the outcome was not as good as expected due to hemorrhage during surgery, which prevented complete exision. Following surgery, the patient exhibited limited functional improvement and limb lightening. The patient was subsequently administered anticoagulant therapy with enoxaparin (8,000 IU, daily for one year) and underwent regular follow up examinations every three months for the first year and every six months subsequently. At the time of writing, the patient was well with a good prognosis.

 Discussion

EN is a rare clinical manifestation associated with the NF1 phenotype. The condition should be defined as early and excessive growth in the width and length of the affected limb due to a neoplastic proliferation of the perineural connective tissue, together with congenital lymphatic insufficiency and chronic hyperemia. While no more than 30 cases are described in the literature (Table I) (12–32), the real incidence is estimated to be higher. The clinical expression is characterized by plexiform neurofibromas located in the superficial or deep nervous system associated with congenital lymphangiomathosis. Signs usually appear during the first years of life, due to lymphostasis and subsequent lymphedema causing adipocyte metaplasia of the adjacent tissues and chronic hyperemia inducing bone overgrowth and focal gigantism (34).

Distinct superficial dysplastic skin alterations known as pachidermocele or dermatholysis, histologically corresponding to mixoglioma gelatiniforme, must be distinguished from EN in patients affected by NF1 (2).

To date, little evidence is available regarding the role of lymphatic alterations in the pathogenesis of EN.

Based on the bilateral lymphatic defect, the presence of a primary lymphatic disease in the current NF1 patient can be hypothesized. The disease is probably supported by a dysplastic-hypertrophic condition as a result of a congenital alteration of the lymphatic network (35,36).

Regarding the lymph to fat transformation, it is known that lymphostasis due to primary and secondary lymphedema determines the transformation of fat cells, resulting in hypertrophied adipose tissue. Several studies (37–39) have suggested that lymphedema leads to adipose tissue accumulation and fibrosis. Moreover, we believe that this process is amplified in NF1 and in EN due to a primary lymphatic disorder, which is at the base of the clinical manifestation induced by the plexiform neurofibroma growth.

Overall, the diagnostic criteria for NF can be improved by the introduction and application of novel criteria based on a wider case series (EN, focal gigantism, mixoglioma gelatiniforme and primary lymphatic disorder), leading to the early diagnosis of NF1, particularly in pediatric patients. LS and MRI can be efficacious tools in the diagnosis and clinical characterization of early onset cutaneous, subcutaneous and skeletal anomalies.

 Acknowledgements

The authors would like to thank Dr Federica Arginelli for providing useful comments.

 Abbreviations NF1

neurofibromatosis type 1

 EN

elephantiasis neuromatosa

 LS

lymphoscintigraphy

 MRI

magnetic resonance imaging

 3D-CT

three-dimensional computed tomography

 References BanoSPrasadAYadavSNChaudharyVSachdevaNElephantiasis neuromatosa of the lower limb in a patient with neurofibromatosis type-1: A case report with imaging findingsJ Pediatr Neurosci55963201010.4103/1817-1745.6668421042513 PollockGReport of a case of molluscum fibrosum or fibroma with observationsMed Chir Trans56255266187310.1177/09595287730560011720896408 SerradellAPNeurocutaneous syndromesMedicine - Programa de formación médica continuada acreditado8553255472003(In Spanish)10.1016/S0304-5412(03)71024-5 PontiGMartoranaDPellacaniGRuiniCLoschiPBaccaraniADeSantis GPollioANeriTMMandelVDNF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignanciesAnticancer Res3430213030201424922668 FlanaganBPHelwingEBCutaneous lymphangiomaArch Dermatol1132430197710.1001/archderm.113.1.24831620 FoeldiMThe role of the lymphatic circulation in the fluid circulation of the eye and the central nervous systemArch Kreislaufforsch41186212196314051391 LohrmannCPacheGFelmererGFoeldiESchaeferOLangerMPosttraumatic edema of the lower extremities: Evaluation of the lymphatic vessels with magnetic resonance lymphangiographyJ Vasc Sur49417423200910.1016/j.jvs.2008.08.069 De LucaABottilloIDasdiaMCMorellaALanariVBernardiniLDivonaLGiustiniSSinibaldiLNovelliADeletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplificationJ Med Genet44800808200710.1136/jmg.2007.05378518055911 De LucaABuccinoAGianniDManginoMGiustiniSRichettaADivonaLCalvieriSMingarelliRDallapiccolaBNF1 gene analysis based on DHPLCHum Mutat21171172200310.1002/humu.911112552569 International society of lymphology: The diagnosis and treatment of peripheral lymphedema. 2009 consensus document of the international society of lymphologyLymphology425160200919725269 PeckingAPPossibilities and restriction of isotopic lymphography for the assessment of therapeutic effects in lymphedemaWien Med Wochenschr149105106199910378340 SpittelRLFernandoSEA case of elephantiasis neuromatosaBr Med J1596597192910.1136/bmj.1.3560.59620774577 WestcottRJAckermanLVElephantiasis neuromatosa; a manifestation of von Recklinghausen's diseaseArch Derm Syphilol55233241194710.1001/archderm.1947.0152002008800620286478 LensonNNeurofibromatosis; a case report of elephantiasis neuromatosa of the right lower extremity, with invasion of the popliteal arteryAMA Arch Surg73279284195610.1001/archsurg.1956.0128002009301813354124 FethiereWCarterHWSturimHSElephantiasis neuromatosa of the penis. Light and electron microscopical studiesArch Pathol9732633019744818737 YaghmaiITafazoliMMassive subperiosteal hemorrhage in neurofibromatosisRadiology122439441197710.1148/122.2.439402017 StyJRStarshakRJWoodsGANeurofibromatosis: Lymphoscintigraphic observationsClin Nucl Med6264265198110.1097/00003072-198106000-000086784997 HarrisWCJrAlpertWJMarcinkoDEElephantiasis neuromatosa in von Recklinghausen's disease. A review and case reportJ Am Podiatry Assoc727072198210.7547/87507315-72-2-706802894 HolckSMedgyesiSDarreELassenMElephantiasis neuromatosa. A light, immunohistochemical and electron microscopic studyVirchows Arch A Pathol Anat Histopathol404427434198410.1007/BF006952266437075 BirchPDDaviesAMThe value of computed tomography in elephantiasis neuromatosaBr J Radiol617678198810.1259/0007-1285-61-721-763126850 HertzanuYHirschMPeiserJAvinoachIComputed tomography of elephantiasis neuromatosaJ Comput Assist Tomogr13156158198910.1097/00004728-198901000-000402910937 BardelliAMHadjistilianouTBuphthalmos and progressive elephantiasis in neurofibromatosis. A report of three casesOphthalmic Paediatr Genet10279286198910.3109/138168189090098832516898 KuoLAKuoRSPlexiform neurofibromatosis: A difficult surgical problemAust N Z J Surg60732735199010.1111/j.1445-2197.1990.tb07464.x2118756 RoySMGhoshAKElephantiasis neuromatosa: A clinicopathologic study of four casesJ Ind Med Assoc901851871992 KokandkarHRVyasASKumbhakarnaNRTotalaRJCongenital plexiform neurofibroma with a sarcomatous nodule in a three month old childIndian J Cancer3113013219947927446 MünteTFMatzkeMJohannesSDietrichBDenglerRMRI of elephantiasis neuromatosaJ Neurol243619199610.1007/BF009009558865034 StevensKJLudmanCNSullyLPrestonBJMagnetic resonance imaging of elephantiasis neuromatosaSkeletal Radiol27696701199810.1007/s0025600504629921933 AkyolMOzçelikSMarufihahMElagözSElephantiasis neuromatosa and Becker's melanosisJ Dermatol26396398199910405488 LorberboymMTrejoLLamplYBone scintigraphy of elephantiasis neuromatosa in Von Recklinghausen's diseaseClin Nucl Med25812813200010.1097/00003072-200010000-0001211043722 SteenbruggeFPoffynBUyttendaeleDVerdonkRVerstraeteKNeurofibromatosis, gigantism, elephantiasis neuromatosa and recurrent massive subperiosteal hematoma: A new case report and review of 7 case reports from the literatureActa Orthop Belg67168172200111383296 HouraniRRizkTKungSBoudghèneFElephantiasis neuromatosa in neurofibromatis type I. MRI findings with review of the literatureJ Neuroradiol336266200610.1016/S0150-9861(06)77230-316528208 Martínez-GarcíaSVera-CasañoAEloy-GarcíaCarrasco Cdel Boz-GonzálezJMartínez-PilarLCrespo-ErchigaVElephantiasis neuromatosa in a patient with neurofibromatosis type 1J Eur Acad Dermatol Venereol22103105200810.1111/j.1468-3083.2007.02221.x18181981 HoshiMIeguchiMTaguchiSYamasakiSA case report of surgical debulking for a huge mass of elephantiasis neuromatosaRare Tumors1e11200910.4081/rt.2009.e1121139882 HoltJF1977 Edward B. D. Neuhauser lecture: Neurofibromatosis in childrenAJR AM J Roentgenol130615639197810.2214/ajr.130.4.615205122 LiuNFYanZXWuXFClassification of lymphatic-system malformations in primary lymphoedema based on MR lymphangiographyEur J Vasc Endovasc Surg44345349201210.1016/j.ejvs.2012.06.01922831870 PrestonJMStarshakRJOechlerHWNeurofibromatosis: Unusual lymphangiographic findingsAJR Am J Roentgenol132474476197910.2214/ajr.132.3.474106665 RyanTJLymphatics and adipose tissueClin Dermatol13493498199510.1016/0738-081X(95)00092-T8665460 RosenEDThe molecular control of adipogenesis, with special reference to lymphatic pathologyAnn N Y Acad Sci979143158discussion 188–196200210.1111/j.1749-6632.2002.tb04875.x12543724 BrorsonHLiposuction normalizes-in contrast to other therapies-lymphedema-induced adipose tissue hypertrophyHandchir Mikrochir Plast Chir44348354201223283813

(A) Clinical aspect of elephantiasis neuromatosa. (B) Severe dorso-lumbar-sacral scoliosis with convexity on the left and preponderance of adipose tissue in the elephantiasic limb, corresponding to three-quarters of its whole volume, as detected by three-dimensional computed tomography scan and magnetic resonance imaging. (C) Conventional lymphoscintigraphy performed to assess the lower limb lymphatic drainage pathway: Images obtained at 60 and 120 min post-injection showed bilateral lower limb lymph flow delay.

EN as a clinical manifestation associated with the NF1 phenotype.

First author/s, year (ref.) Gender Age/age of onset Proband affected region Family history Clinical features
Spittel and Fernando, 1929 (12) M 20 years/at birth Left limb Grandmother, 2,000 minute cutaneous tumours and scattered subcutaneous swellings; mother, achondroplasia. Gross EN of the left limb. Subcutaneous tumors scattered all over the body; a pachidermatocele of the occipital scalp; cutaneous freckles. Hyperpigmentation of the mucous membrane of the mouth, and muddy hypopigmentation of the conjunctive. Bone development increasing.
Westcott and Ackerman, 1947 (13) M 40 years/at birth Neck His mother had NF-1. EN of the neck. Asymmetry of the rib cage. Deformity of the cervical column, the left leg and the left clavicle.
M 22 years/childhood Chest wall and axilla No particular familial history of NF. EN of extensively involved the chest wall and the axilla.
Lenson, 1956 (14) F 42 years/– Right leg The family history is free from NF or any other inherited disease tendency. Her mother had gastric carcinoma. Soft irregular bluish end mottled mass involving the distal two-thirds of the right lower extremity. Cavernous haemangioma with the consistency of a lipoma. Numerous femoral cysts.
Fethiere et al, 1974 (15) M 16 years/childbirth Penis Not reported. EN of the penis. Syringomyelia associated with cervical ependymoma. Facial paralysis on the left side and paralysis of the left eye muscle. Multiple schwannomas involving certain cranial nerves, and numerous dorsal and ventral spinal roots with large tumor formations in cauda equina roots.
Yaghmai and Tafazoli, 1977 (16) M 11 years/3 years Left thigh Not reported. Elephantiasis neuromatosa and overgrowth of abnormal bones with subperiosteal haemorrhage. Numerous cafè-au-lait spots and scoliosis of the dorsolumbar spine.
F 9 years/2 years Right leg Not reported. Elephantiasis neuromatosa, multiple cafè-au-lait spots and overgrowth of abnormal bones with subperiosteal haemorrhage.
Sty et al, 1981 (17) M 4 years/– Right lower extremity NF in 11 of his relatives. EN involving the right lower extremity. Numerous cafè-au-lait spots on the lower abdomen and groin. The right lower extremity was longer than the left. Dilation of the medial lymphatic channels in the lower extremity and enlarged right iliac nodes.
Harris et al, 1982 (18) F 18 years/at birth Right hallux No familial history of NF. Only one large cafè-au-lait spot on the right hallux. Soft-tissue hypertrophy with massive enlargement of the proximal and distal phalanges.
Holck et al, 1984 (19) F 17 years/childhood Right gluteal sulcus There was no predisposition to either familial or hereditary disorders. EN of the right gluteal sulcus, coexistent or with lipomatosis. No skeletal lesion. Nor were other stigmata of von Recklinghausen's disease apparent.
Birch and Davies, 1988 (20) F 30 years/at birth Left lower limb Not reported. EN of the left lower limb maximal in the calf. Dysplastic bones of the left hemipelvis and leg with florid osseous striations. The skin of the thigh was loose and inelastic.
Hertzanu et al, 1989 (21) F 52 years/childhood Trunk The patient denied any manifestations of NF in her family. Symmetric EN of the trunk. At 32 years: Hypovolemic shock due to massive hemorrhage into the mass.
Bardelli and Hadjistilianou, 1989 (22) M Few months/at birth Facial hemi-hypertrophy No family history of congenital glaucoma or buphthalmos. Buphthalmos and regional gigantism with evolution in EN. Corneal diameter 13 mm, rubeosis iridis, ectropion uveae. An increase of optic nerve cupping. A swelling of the right upper lid and preauricular region. Hypertrophy of the soft periorbital tissues. Small nodules on conjunctiva of affected eye.
Bardelli and Hadjistilianou, 1989 (22) M 13 months/at birth Right orbital region Not reported. Buphthalmos. An enlarged optic canal, a fibrous dysplasia of the greater wing of sphenoid bone. Longer right fibula and a slight deformity of the vertebrae of the lumbar tract.
F 11 years/at birth Temporal and zygomatic region Not reported. Facial elephantiasis without buphthalmos. Greater wing of sphenoid bone; right optic foramen larger than the left. Iris nodules, ectropion, uveae, increased optic nerve cupping. Small neurofibromas of the zygomatic and temporal region.
Kuo and Kuo, 1990 (23) F 34 years/8 years Right limb and His mother, grandmother, sister and EN involving the right lower limb and pelvis, leading to a right hip pelvis nephews had NF. disarticulation. Grossly enlarged lower limb complicated by infected decubitus ulcers. A leg length discrepancy. (After surgery a large neurofibroma of the sciatic nerve).
Roy and Ghosh, 1992 (24) F 22 years/at birth Right foot No family history of NF1 was presented. Enlargement of the whole right foot with conspicuous gigantism of the 2nd to 5th toes. The overlying skin was coarse, dry, thick. Overgrowth and elongation of all the bones of the foot (2nd and 3rd metatarsals, and their phalanges). A huge soft-tissue mass with no bone involvement.
M 21 years/at birth Right foot Not reported. Gigantism of the right foot and elongation of the all the bones of the foot (metatarsals and a huge soft-tissue mass).
M 18 years/early childhood Right foot His father had EN. One of his three brothers has a few cutaneous nodules affecting the right lower limb only. Gigantism of the right foot with swelling at the heel. Elongation of all the bones (metatarsals and a soft-tissue mass affecting mainly the hind foot).
M 6 years/at birth Right foot No family history of NF. Enlargement mainly of the forefoot and the swelling was more prominent between the great and 2nd toe. No cafè-au-lait spots.
Kokandkar et al, 1994 (25) M 3 months/at birth Neck and back Family history did not reveal occurrence of similar illness in any member. Congenital plexiform neurofibroma involving the neck with EN with a sarcomatous nodule. The skin covering the tumor was hairy, redundant and dark. The skin covering the nodules was thinned out and ulcerated.
Münte et al, 1996 (26) F 33 years/6 years Right leg Family history of NF. EN of the right leg. Severe dysaesthesia in the right lower leg not confined to a single nerve.
Stevens et al, 1998 (27) M 43 years/childhood Left leg Not reported. Gross EN of the left leg. Large synovial cyst arising from the synovium of the patello-femoral joint.
Akyol et al, 1999 (28) M 20 years/6 years old Left shoulder and arm No family history of NF. EN with Becker's melanosis. Hairly and brown-black hyperpigmented patches on left shoulder, left upper back and left arm. Lisch nodules.
Lorberbom et al, 2000 (29) M 35 years/– Right thigh and sacral region Not reported. A soft-tissue mass and enlargement of the right upper leg.
Steenbrugge et al, 2001 (30) F 13 years/at birth Left limb Her mother had NF-I. Left leg elephantiasis with recurrent massive subperiosteal hematoma.
Hourani et al, 2006 (31) F 41 years/childhood Right limb Not reported. EN of the right leg. Optic chiasm glioma. Right tibia and fibula marrow and cortices hypertrophy.
Martínez-García et al, 2008 (32) F 14 years/at birth Right limb Not reported. EN involving the right lower limb. Anaemia and hepatitis B.
Hoshi et al, 2009 (33) M 56 years/childhood Right leg There was no particular family history of NF. A huge mass of EN in the right leg.
Bano et al, 2010 (1) M 15 years/childhood Right limb No family history of NF1 in first-degree relatives. EN of the right leg. Osseous abnormalities including thinning of bones, erosion of distal articular surfaces and periosteal dysplasia.

NF1, neurofibromatosis type 1; EN, elephantiasis neuromatosa.